HA
SRRA

Havens Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Havens Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,350
Closed -$789K – 60
2022
Q2 		$789K Buy
+14,350
New +$753K 1.25% 24

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Havens Advisors's SRRA Position: Q3 2022 in Review

Havens Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 14,350 shares — an estimated $789K sold.

Havens Advisors first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $789K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Havens Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Havens Advisors sold 14,350 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $789K.
  • Havens Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Havens Advisors's Sierra Oncology, Inc. Common Stock position peaked at $789K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Havens Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.